We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-8.74%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.03B
AUM Growth
-$97.2M
Cap. Flow
+$5.15M
Cap. Flow %
0.5%
Top 10 Hldgs %
54.98%
Holding
5,775
New
1,132
Increased
1,485
Reduced
1,487
Closed
1,545

Sector Composition

Rank Sector Weight
1 Financials 2.17%
2 Healthcare 1.69%
3 Industrials 1.67%
4 Technology 1.59%
5 Consumer Discretionary 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDZI icon
1676
Cadiz
CDZI
$291M
$21K ﹤0.01%
2,847
+1,724
+154% +$14.2K
FARO
1677
DELISTED
Faro Technologies
FARO
$21K ﹤0.01%
614
+609
+12,180% +$24.1K
FCCO icon
1678
First Community Corp
FCCO
$322M
$21K ﹤0.01%
1,727
+1,557
+916% +$18.9K
FFA
1679
First Trust Enhanced Equity Income Fund
FFA
$467M
$21K ﹤0.01%
1,719
+150
+10% +$2.05K
FNV icon
1680
Franco-Nevada
FNV
$46B
$21K ﹤0.01%
477
-2,834
-86% -$122K
LPSN icon
1681
LivePerson
LPSN
$32.3M
$21K ﹤0.01%
184
-312
-63% -$42.2K
LXU icon
1682
LSB Industries
LXU
$693M
$21K ﹤0.01%
1,816
-628
-26% -$13.9K
MTRX icon
1683
Matrix Service
MTRX
$335M
$21K ﹤0.01%
921
+475
+107% +$9.62K
PSHG icon
1684
Performance Shipping
PSHG
$21.8M
0
RGNX icon
1685
Regenxbio
RGNX
$708M
$21K ﹤0.01%
+940
New +$24K
RJF icon
1686
Raymond James Financial
RJF
$34B
$21K ﹤0.01%
621
-2,510
-80% -$93K
RKDA icon
1687
Arcadia Biosciences
RKDA
$1.52M
$21K ﹤0.01%
+9
New +$37.5K
SR icon
1688
Spire
SR
$4.85B
$21K ﹤0.01%
392
-3,108
-89% -$165K
TRUP icon
1689
Trupanion
TRUP
$1.18B
$21K ﹤0.01%
2,774
-152
-5% -$1.2K
UVE icon
1690
Universal Insurance Holdings
UVE
$1.23B
$21K ﹤0.01%
700
-764
-52% -$20.6K
VGSH icon
1691
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$21K ﹤0.01%
338
+335
+11,167% +$20.5K
W icon
1692
Wayfair
W
$14.6B
$21K ﹤0.01%
590
-1,416
-71% -$54.3K
WILC icon
1693
G. Willi-Food International
WILC
$403M
$21K ﹤0.01%
4,774
+758
+19% +$3.88K
EVFM
1694
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$21K ﹤0.01%
+29
New +$31.1K
RDS.B
1695
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$21K ﹤0.01%
451
+386
+594% +$20.8K
PTVCB
1696
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$21K ﹤0.01%
1,001
+233
+30% +$5.33K
RP
1697
DELISTED
RealPage, Inc.
RP
$21K ﹤0.01%
1,273
+1,227
+2,667% +$22.8K
FPRX
1698
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$21K ﹤0.01%
1,364
+862
+172% +$18.5K
CCMP
1699
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$21K ﹤0.01%
532
+148
+39% +$6.46K
PMC
1700
DELISTED
PharMerica Corporation
PMC
$21K ﹤0.01%
739
-1,861
-72% -$62.5K

Similar funds

Tower Research Capital (TRC)'s Q3 2015 Portfolio in Review

As of Q3 2015, Tower Research Capital (TRC) held 5,775 positions worth $1.03B, down 8.6% from $1.13B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC)'s Q3 2015 filing shows 1,132 new, 1,485 increased, 1,487 reduced and 1,545 closed positions. Its largest new stake was iShares Russell 2000 ETF: 144,546 shares worth $15.8M. The largest sale was VanEck Semiconductor ETF, an estimated $34M.

By sector, the portfolio is most concentrated in Financials at 2.2% of assets, down from 2.5% a quarter earlier, followed by Healthcare and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2015 buy was iShares Russell 2000 ETF: 144,546 shares worth $15.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2015, an estimated $37.1M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2015 reduction was VanEck Semiconductor ETF, cutting an estimated $34M.
  • Tower Research Capital (TRC) fully exited Vanguard Extended Market ETF in Q3 2015, selling an estimated $10M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.03B portfolio in Q3 2015.
  • Tower Research Capital (TRC) opened 1,132 new positions and closed 1,545 in Q3 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 8.6% quarter-over-quarter to $1.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2015, filed 13 Nov 2015.